Pafolacianine Injection for Intraoperative Imaging of Folate Receptor–Positive Ovarian Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)
J. Clin. Oncol 2022 Sep 07;[EPub Ahead of Print], JL Tanyi, LM Randall, SK Chambers, KA Butler, IS Winer, CL Langstraat, ES Han, AL Vahrmeijer, HS Chon, MA Morgan, MA Powell, JH Tseng, AS Lopez, RM WenhamFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.